Moderna (MRNA) Long-Term Investments (2017 - 2026)
Moderna (MRNA) reported Long-Term Investments of $1.77 billion for Q2 2026, down 25.4% from $2.37 billion a year earlier and down 21.3% from the prior quarter.
Moderna (MRNA) Long-Term Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna posted Long-Term Investments of $2.34 billion, down 6.3% from FY2024.
- Long-Term Investments has declined for three consecutive years, though with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $2.49 billion in FY2024 (-46.7%), $4.68 billion in FY2023 (-43.8%), $8.32 billion in FY2022 (+21.6%) and $6.84 billion in FY2021 (+970.9%).
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Investments since Q1 2021.
- Year over year, Long-Term Investments has now declined in each of the last four quarters, with an average decline of 22.6% over the last eight quarters.
- The high point for year-over-year Long-Term Investments in five years was Q4 2021 (growth of 970.9%); the low point was Q2 2024 (a decline of 61.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.25 billion (Q1 2026), $2.34 billion (Q4 2025) and $2.14 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 1.77 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.77 Bn |
| Mar 31, 2026 | 2.25 Bn |
| Dec 31, 2025 | 2.34 Bn |
| Sep 30, 2025 | 2.14 Bn |
| Jun 30, 2025 | 2.37 Bn |
| Mar 31, 2025 | 2.42 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.34 Bn |
| Jun 30, 2024 | 2.33 Bn |
| Mar 31, 2024 | 3.64 Bn |
| Dec 31, 2023 | 4.68 Bn |
| Sep 30, 2023 | 5.27 Bn |
| Jun 30, 2023 | 6.11 Bn |
| Mar 31, 2023 | 7.44 Bn |
| Dec 31, 2022 | 8.32 Bn |
| Sep 30, 2022 | 8.66 Bn |
| Jun 30, 2022 | 10.16 Bn |
| Mar 31, 2022 | 9.17 Bn |
| Dec 31, 2021 | 6.84 Bn |
| Sep 30, 2021 | 6.44 Bn |
Moderna Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();